Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 1637-1646 |
| Number of pages | 10 |
| Journal | Clinical case reports |
| Volume | 7 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2019 |
Cite this
}
Comprehensive evaluation of gait, spasticity, and muscle morphology : A case report of a child with spastic paresis treated with Botulinum NeuroToxin-A, serial casting, and physiotherapy. / Weide, Guido; Sloot, Lizeth; Oudenhoven, Laura; Jaspers, Richard T.; Harlaar, Jaap; Buizer, Annemieke; Bar-On, Lynn.
In: Clinical case reports, Vol. 7, No. 9, 2019, p. 1637-1646.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Comprehensive evaluation of gait, spasticity, and muscle morphology
T2 - A case report of a child with spastic paresis treated with Botulinum NeuroToxin-A, serial casting, and physiotherapy
AU - Weide, Guido
AU - Sloot, Lizeth
AU - Oudenhoven, Laura
AU - Jaspers, Richard T.
AU - Harlaar, Jaap
AU - Buizer, Annemieke
AU - Bar-On, Lynn
PY - 2019
Y1 - 2019
N2 - Comprehensive instrumented muscle and joint assessments should be considered when prescribing Botulinum NeuroToxin-A (BoNT-A) treatment in spastic paresis. In a child with spastic paresis, comprehensive evaluation following treatment with BoNT-A, serial casting, and physiotherapy showed that short-term improvements in gait occurred without changes in muscle morphology. Rather, foot flexibility increased.
AB - Comprehensive instrumented muscle and joint assessments should be considered when prescribing Botulinum NeuroToxin-A (BoNT-A) treatment in spastic paresis. In a child with spastic paresis, comprehensive evaluation following treatment with BoNT-A, serial casting, and physiotherapy showed that short-term improvements in gait occurred without changes in muscle morphology. Rather, foot flexibility increased.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073242673&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31534717
U2 - 10.1002/ccr3.2227
DO - 10.1002/ccr3.2227
M3 - Article
VL - 7
SP - 1637
EP - 1646
JO - Clinical case reports
JF - Clinical case reports
SN - 2050-0904
IS - 9
ER -